These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 30042152)
1. miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes. Croset M; Pantano F; Kan CWS; Bonnelye E; Descotes F; Alix-Panabières C; Lecellier CH; Bachelier R; Allioli N; Hong SS; Bartkowiak K; Pantel K; Clézardin P Cancer Res; 2018 Sep; 78(18):5259-5273. PubMed ID: 30042152 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets‑1 network in triple-negative breast cancer. Li W; Liu C; Zhao C; Zhai L; Lv S Int J Oncol; 2016 Mar; 48(3):1155-64. PubMed ID: 26781040 [TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen. McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways. Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050 [TBL] [Abstract][Full Text] [Related]
5. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway. Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204 [TBL] [Abstract][Full Text] [Related]
6. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease. Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212 [TBL] [Abstract][Full Text] [Related]
7. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo. Mohammadi-Yeganeh S; Hosseini V; Paryan M J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1. Chen LL; Zhang ZJ; Yi ZB; Li JJ Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidence. Awolaran O; Brooks SA; Lavender V Breast; 2016 Dec; 30():156-171. PubMed ID: 27750106 [TBL] [Abstract][Full Text] [Related]
10. Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3. Muhammad N; Bhattacharya S; Steele R; Ray RB Oncotarget; 2016 Sep; 7(36):58595-58605. PubMed ID: 27517632 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2. Ni X; Xia T; Zhao Y; Zhou W; Wu N; Liu X; Ding Q; Zha X; Sha J; Wang S Cancer Sci; 2014 Jan; 105(1):18-25. PubMed ID: 24164962 [TBL] [Abstract][Full Text] [Related]
12. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer. Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157 [TBL] [Abstract][Full Text] [Related]
13. MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3. Wei W; Yang Y; Cai J; Cui K; Li RX; Wang H; Shang X; Wei D Cell Physiol Biochem; 2016; 39(3):1165-76. PubMed ID: 27576787 [TBL] [Abstract][Full Text] [Related]
14. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Guo GC; Wang JX; Han ML; Zhang LP; Li L Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer. Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943 [TBL] [Abstract][Full Text] [Related]
16. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer. Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721 [TBL] [Abstract][Full Text] [Related]
17. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2. Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238 [TBL] [Abstract][Full Text] [Related]
18. lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Eades G; Wolfson B; Zhang Y; Li Q; Yao Y; Zhou Q Mol Cancer Res; 2015 Feb; 13(2):330-8. PubMed ID: 25253741 [TBL] [Abstract][Full Text] [Related]
19. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer. Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway. Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]